SCHEMBL7284034

SCHEMBL7284034

Cc1c(CN2CCc3c(c4cccc(F)c4n3C)C2=O)ncn1C(=O)OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.42
HTR2A P28223 2/20 0.42
HTR2C P28335 2/20 0.42
HTR2B P41595 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
ADRA2C P18825 1/20 0.42
ADRA1A P35348 1/20 0.42
HTR3A P46098 1/20 0.42
CASP6 P55212 1/20 0.42
LMNA P02545 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 1/20 0.34
PTGDR2 Q9Y5Y4 4/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
GRM5 P41594 1/20 0.33
HTT P42858 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC10 Q969S8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1133 0.88 KCNH2 (0.56) KCNH2HTR2AHTR2CHTR2BCYP1A2
SCHEMBL7295411 0.81 HTR2A (0.49) KCNH2HTR2AHTR2CHTR2BCYP1A2
SCHEMBL7285963 0.79 KCNH2 (0.45) KCNH2HTR2AHTR2CHTR2BCYP1A2
SCHEMBL9485728 0.78 KCNH2 (0.44) KCNH2HTR2AHTR2CHTR2BCYP1A2
SCHEMBL9485723 0.77 HTR2A (0.44) KCNH2HTR2AHTR2CHTR2BCYP1A2
SCHEMBL9485681 0.76 KCNH2 (0.44) KCNH2HTR2AHTR2CHTR2BCYP1A2
Lurosetron SCHEMBL7284073 0.74 KCNH2 (0.65) KCNH2HTR2AHTR2CHTR2BCYP1A2
Lurosetron SCHEMBL788289 0.73 KCNH2 (0.72) KCNH2HTR2AHTR2CHTR2BCYP1A2
Lurosetron SCHEMBL30949356 0.73 KCNH2 (0.72) KCNH2HTR2AHTR2CHTR2BCYP1A2
Lurosetron SCHEMBL7282816 0.73 KCNH2 (0.63) KCNH2HTR2AHTR2CHTR2BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0353983-B1 Lactam derivatives GLAXO GROUP LTD (GB) 1996-05-29 EP disclosed
US-5183820-A Useful for treatment of nausea, vomiting, irritable bowel syndrome and dyspepsia GLAXO GROUP LIMITED (GB) 1993-02-02 US disclosed
EP-0353983-A2 Lactam derivatives GLAXO GROUP LIMITED (GB) 1990-02-07 EP disclosed